From lab to market: The PacifiCan and ARTMS partnership

Global medical isotope shortages? Thankfully, ARTMS has a solution.

Medical isotopes are used in cancer, cardiac and lung disease diagnosis. Burnaby-based ARTMS is producing groundbreaking technology allowing medical providers to generate their own essential isotopes.

ARTMS holds exclusive global commercialization rights to its award-winning, proprietary Quantum Irradiation System (QIS) hardware which enables hospitals and other medical facilities to use their pre-existing equipment to produce Tc-99m along with other medical isotopes.

The result? Less global shortage, which means more medical knowledge and more efficient diagnoses. This also helps physicians and researchers to produce radioisotopes locally and in a cost-effective manner.

$1.5M in PacifiCan funding has helped ARTMS:

• commercialize new product lines while growing export sales
• form partnerships within the radiopharmaceutical industry
• create 44 high-quality jobs
• expand their physical presence with a new facility